# Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular Drainage

> **NCT06119061** · PHASE4 · RECRUITING · sponsor: **Aaron Cook** · enrollment: 20 (estimated)

## Conditions studied

- Subarachnoid Hemorrhage, Aneurysmal

## Interventions

- **DRUG:** Telavancin Injection

## Key facts

- **NCT ID:** NCT06119061
- **Lead sponsor:** Aaron Cook
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-02
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-12-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06119061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06119061, "Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular Drainage". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT06119061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*